Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
XENE
#1551
Xenon Pharmaceuticals Inc. - Common Shares
36.4
4
USD
+0.01%
Market Price
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+0.77%
Monthly Change
-38.61%
6 month change
-37.73%
Year Change
-10.66%
Previous Close
36.1
6
Open
36.0
5
Low
35.9
8
High
36.7
0
Markets
US Stock Market
Healthcare
Biotechnology
XENE
1D
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Documents
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
Current
Key stats
Total common shares outstanding
35.81 M
51.92 M
63.04 M
75.43 M
76.54 M
83.19 M
96.84 M
Valuation ratios
Enterprise value
524.36 M
1.45 B
2.29 B
3.24 B
2.86 B
3.53 B
3.29 B
Price to earnings ratio
—
—
-18.09
-16.45
-13.02
-10.28
-7.43
Price to sales ratio
—
—
239.11
15.1 K
2 869.8
473.62
—
Price to cash flow ratio
—
—
22.92
20.67
16.83
-12.73
-9.01
Price to book ratio
—
—
3.13
3.24
4.04
6.11
0.84
Enterprise value to EBITDA ratio
-16.87
—
-17.74
—
—
—
—
Profitability ratios
Return on assets %
-0.15
-0.14
-0.17
-0.19
-0.29
-0.55
-0.09
Return on equity %
-0.17
-0.14
-0.17
-0.2
-0.31
-0.59
-0.09
Return on invested capital %
-509.62
-2 537.53
-614.65
-359.58
-452.44
-2 021.28
-154.83
Gross margin %
100
100
100
100
100
100
—
Operating margin %
-97.31
-428.45
-1 368.91
-107.56 K
26.25 K
-4 974.27
—
EBITDA margin %
-96.64
—
-1 368.91
—
—
—
—
Net margin %
-89.65
-427.85
-1 328.95
-91.65 K
22.02 K
-4 612.13
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
12.3
39.03
26.44
23.65
17.85
13.42
21.02
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.19
0.05
0.01
0
-0
0.01
0
Solvency ratios
Debt to assets ratio
0.06
—
—
—
—
—
—
Debt to equity ratio
0.06
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
—
-1.63
-2.17
-2.33
-3.52
-3.91
EBIT per share
—
—
-2.13
-3.2
-3.57
-4.71
-5.12
EBITDA per share
—
—
-2.13
—
—
—
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
—
14.35
9.75
8.05
6.93
17.49
Net current asset value per share
—
—
9.92
9.64
8.16
7.07
9.5
Tangible book value per share
—
—
11.92
13.87
9.69
7.34
12.47
Working capital per share
—
—
9.54
9.23
7.7
6.55
9.04
Book value per share
—
—
11.92
13.87
9.69
7.34
12.47
News
Guggenheim Assumes Xenon Pharmaceuticals at Buy, Announces Price Target of $73
Stocks Finish Mostly Higher as Crude Prices Fall
XENE Stock Plummets as Xenon Pharmaceuticals Pauses Drug Trial
12 Health Care Stocks Moving In Friday's Intraday Session
Xenon: The Psychiatry Pause Matters More Than You Think (Rating Downgrade) (NASDAQ:XENE)
Dow Falls Over 200 Points; Xenon Pharmaceuticals Shares Plunge
Xenon Stock Reaction Is Overblown: Analyst
Stocks Waver as Bond Yields Climb
XENE Files NDA for Epilepsy Drug, Falls on Depression Studies' Setback
Stocks Mixed as Crude Oil Prices and Bond Yields Rise
RBC Capital Maintains Outperform on Xenon Pharmaceuticals, Lowers Price Target to $70
US Stocks Mixed; Industrial Production Unchanged In August